Article

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individuals

2022-02-23

Abstract excerpt

<h4>Background: </h4> Assessing immune responses after vaccination is part of the evaluation package of vaccine effectiveness in the real world. With regard to SARS-CoV-2, neutralizing antibody levels has been shown to be a good indicator of antibody immune response boosting. So far, limited data have been reported from Africa including in Central Africa. The objective of this study was to provide data on anti-S1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6d8b06dd-fc67-53c3-aa71-dcdc211b4f3a
DOI: 10.21203/rs.3.rs-1338684/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individualsDOI 10.21203/rs.3.rs-1338684/v1Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational studySemantic proximity Read

Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factorsSemantic proximity Read

Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD studySemantic proximity Read

SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity Read

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)Semantic proximity Read

Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity Read

Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)Semantic proximity Read

Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolateSemantic proximity Read

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Semantic proximity Read

Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African populationSemantic proximity Read

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022Semantic proximity Read